Navigation Links
Monsanto Attempts to Lockout Socially Responsible Shareholder at Annual Meeting
Date:1/20/2012

ST. LOUIS, Jan. 20, 2012 /PRNewswire-USNewswire/ -- On Tuesday, January 24 at 1:30 PM, Monsanto officers and shareholders will vote on a shareholder proposal to create a study of "material financial risks or operational impacts" associated with its chemical products and genetically modified organisms (GMOs).

The proposal represents one of the strongest signals to date that the biotech food conglomerate is facing growing consumer, legal, and regulatory uncertainties. As of today, however Monsanto has told John Harrington that they will not recognize his proxy who would speak on behalf of the resolution for only three minutes under normal circumstances.

The meeting itself is only open to shareholders but concerned citizens will be demonstrating outside the northeast entrance to Monsanto's Lindberg campus beginning at 12:00 noon. Monsanto Headquarters is located at 800 North Lindberg Boulevard in St. Louis, MO.

Adam Eidinger, an organic food activist who recently led a walk from NY to Washington DC on behalf of honest food labeling, will present the shareholder resolution on behalf of Napa, California based Harrington Investments (HII) with help from the Pesticide Action Network of North America (PANNA).

Eidinger will be available for interview before and after the shareholder meeting, which he will drive a "Label GMO" art car to attend. Representatives from HII and PANNA will be also available for interview before and after the shareholder meeting. Eidinger's written testimony is available by request.

In its statement recommending shareholders to vote against the HII resolution, Monsanto management stated that, "Farmers should have the freedom to choose which production method is best suited for their needs, whether organic, non-GM conventional or biotechnology traits. All of these systems can and do work effectively side by side…"

John Harrington, CEO of Harrington Investments questions the veracity of Monsanto's statement: "While I am heartened by Monsanto's sudden concern for the freedom of farmers, the unfortunate reality facing American farmers right now, is that genetic drift from GMO crops is contaminating their conventional and organic crops. This can be disastrous because many GMO crops cannot be sold to important markets, such as Europe, China and Japan. The potential legal implications for Monsanto are staggering."

Eidinger, who organized last October's a 100 person, 313 mile "Right2Know March" from New York City to the White House for federally mandated GMO food labeling says: "With the rise or Round-Up resistant 'superweeds' the company is simply telling farmers to spray even more toxic herbicides including 2,4 D, the main ingredient in Agent Orange. Many people are struggling to avoid GMOs and chemicals used on them in the food they eat due to serious health and environmental concerns yet Americans have no right to know what we are eating largely due to the close ties Monsanto has to President Obama's USDA and FDA which has ignored more than 500,000 Americans who have signed on to the JustLabelIt.org petition to the FDA."

More information about the protest may be found at http://www.facebook.com/events/340545799304131/

 

 


'/>"/>
SOURCE Harrington Investments
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Monsanto Declared Worst Company of 2011 by NaturalSociety
2. Monsantos Kerry Preete to Address Investors at Goldman Sachs Agricultural Biotech Forum
3. Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
4. Monsanto Reconfirms 2010 Guidance and 2012 Financial Commitments on Strength of Larger Expected Launches for Blockbuster Products
5. Monsanto Opens First Biotechnology Research Center in China
6. Monsanto and Huazhong Agricultural University Enter Into Collaboration Focusing on Development of Plant Biotechnology
7. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
8. Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event
9. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
10. Monsanto, BASF Scientists Disclose Discovery of Gene Conferring Drought Tolerance in Corn Plants
11. Monsantos Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Denmark , March 22, 2017  Ascendis ... utilizes its innovative TransCon technology to address significant ... financial results for the full year ended December ... significant year for our company as we broadened ... a leading, integrated rare disease company with an ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... 22, 2017   VWR (NASDAQ: ... product and service solutions to laboratory and ... acquired EPL Archives, Inc., an international biorepository ... entire regulated product research, development and commercialization ... and ancillary services. EPL Archives is widely ...
Breaking Biology Technology:
(Date:3/16/2017)... , March 16, 2017 CeBIT 2017 - Against identity fraud with ... Reading ... Used combined in one project, multi-biometric solutions provide a crucial ... Used combined in ... ...
(Date:3/7/2017)...   HireVue , the leading provider of video ... best talent, faster, today announced the additions of ... Diana Kucer as Chief Marketing Officer (CMO). ... poised to drive continued growth in the company,s new ... record bookings in 2017. "Companies worldwide turn ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
Breaking Biology News(10 mins):